本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
MOMENCE, Ill., Nov. 25, 2024 /PRNewswire/ -- FutureCeuticals, Inc. and Global Calcium Pvt., Ltd. announced today a strategic global sales and manufacturing partnership to expand FutureCeuticals' portfolio of clinically proven dietary supplement ingredients into high-growth markets in India, Southeast Asia, the Middle East, and Africa. This partnership leverages Global Calcium's manufacturing and sales network, opening new opportunities in these rapidly growing regions. The partnership will initially focus on FruiteX-B® calcium fructoborate, a patented and clinically supported mineral complex developed by FutureCeuticals, recognized as a leading solution for joint, mobility, and bone health products. By capitalizing on Global Calcium's position in this market, FruiteX-B will offer new opportunities in these regions. Global Calcium's expertise in calcium-based minerals will help expand FruiteX-B's reach and strengthen its global presence in the mineral supplement category. "We are excited to partner with Global Calcium, extending the reach of our innovative ingredient solutions," said J. Randal Wexler, Vice President and Head of Research & Development at FutureCeuticals. "Their world-class manufacturing capabilities align with our high standards, and this opens doors to some of the world's fastest-growing markets. The decision to utilize their capabilities to help us globalize our industry-leading and innovative joint and bone mineral complex made perfect sense." Sahil Vaz, Global Calcium's CEO, echoed Mr. Wexler's sentiment. "We are excited to collaborate with a globally recognized innovator like FutureCeuticals on this strategic venture. Their science-based platform of research-backed ingredients align perfectly with our manufacturing capabilities and business strengths." Mr. Vaz called out FruiteX-B® specifically, sharing, "our initial focus on FutureCeuticals' FruiteX-B calcium fructoborate provides a compelling new joint and bone solution that is a natural extension of our existing, market-leading specialty mineral actives offerings." For sales inquiries regarding FruiteX-B® Calcium Fructoborate in India, Southeast Asia, the Middle East, and Africa, contact: info@globalcalcium.com. For inquiries in North America, Europe, China, and Australia, contact: sales@futureceuticals.com About FutureCeuticals, Inc.FutureCeuticals, Inc. is a leader in the research, development and manufacture of plant-based powders and extracts for the functional food, beverage, and dietary supplement markets. About Global Calcium Pvt., Ltd.Global Calcium, based in Bangalore, India, is a leader in API, drug, and dietary ingredient manufacturing, and offers best-in-class manufacturing standards that serve the world's largest companies with a focus on supplying specialty and organic minerals-based products.
HONG KONG, Nov. 25, 2024 /PRNewswire/ -- HashKey Exchange, the largest* licensed virtual asset exchange in Hong Kong, announced the official launch of its institutional-grade integrated service, HashKey Pro, which aims to enable brokers, banks, payment institutions, and other financial entities to quickly integrate professional and reliable virtual asset trading functionalities. HashKey Pro offers API trading, block trade services, and enterprise-level account structure and permission management. It also provides institutional investors with asset insurance and a globally leading trading matching engine. Through HashKey Pro, financial institutions can allow their customers to trade a range of virtual currencies, including BTC and ETH, in-app or through the website. Leveraging HashKey Pro, HashKey Exchange has partnered with ZA Bank, Hong Kong's first and largest** digital bank, to announce a milestone collaboration. This initiative positions ZA Bank as Asia's first retail-focused bank offering virtual asset trading services. Through HashKey Pro, ZA Bank has successfully integrated virtual asset trading features into its app, allowing Hong Kong retail users to trade Bitcoin (BTC) and Ethereum (ETH), setting a new benchmark for the convergence of digital banking and virtual asset trading. At the press conference, Livio Weng, CEO of HashKey Exchange, stated:"We are honored to collaborate with ZA Bank to drive innovation in Asia's digital banking sector. HashKey Pro, as a one-stop virtual asset solution, enables traditional financial institutions to quickly adopt virtual asset trading capabilities, lowering technological barriers and providing users with a convenient and efficient trading experience. This partnership represents a deep integration of traditional banking with the virtual asset ecosystem, setting a new standard for the industry." Calvin Ng, Alternate Chief Executive of ZA Bank, remarked:"As a digital bank, we fully understand the importance of security and compliance. That's why we've partnered with HashKey Exchange, a globally leading licensed virtual asset exchange, to provide bank-grade security for investors. This will be a core competitive advantage for us in the Asian market." Currently, HashKey Pro has established partnerships with over ten brokers and banks, including ZA Bank and Victory Securities, collectively completing transactions exceeding HKD 5 billion. Since November, HashKey Exchange has experienced remarkable growth, with weekly asset inflows surpassing HKD 1 billion and a weekly growth rate of 17%. As of November 24, user asset inflows on the platform exceeded HKD 7 billion, and total trading volume reached HKD 550 billion, solidifying HashKey Exchange's position as Hong Kong's largest licensed virtual asset exchange. Looking ahead, Weng expressed optimism:"We believe this innovative collaboration has initiated a 'swarm effect.' We can build the best liquidity and trading network in the licensed market by serving and integrating dozens of financial institutions. This will attract more traditional financial institutions to enter the virtual asset market, collectively advancing the industry's compliance and innovative growth. HashKey Pro will continue to partner with more entities, offering users a wider array of digital asset services and accelerating the comprehensive upgrade of the digital economy." * As of November 21, 2024, HashKey Exchange ranks seventh on CoinGecko's exchange list and is the largest licensed virtual asset exchange in Hong Kong.** ZA Bank, the first operational digital bank in Hong Kong (formerly virtual bank), held the highest user count and deposits among Hong Kong's eight digital banks as of June 30, 2024, according to digital bank performance reports."Asia's first" or "Asia's leading" refers to FATF-member countries/regions in Asia (excluding West Asia) with comprehensive virtual asset regulatory frameworks, where licensed banks provide retail investors with fiat-to-crypto trading services via their primary app, as of November 20, 2024. Disclaimer: Hash Blockchain Limited is responsible for the issue of this material in Hong Kong. It is licensed by the Securities and Futures Commission for Types 1 and 7 regulated activities under the Securities and Futures Ordinance, and has obtained a license to operate a virtual asset trading platform under the Anti-Money Laundering and Counter-Terrorist Financing Ordinance (AMLO). HashKey Exchange does not service users from Mainland China, United States and certain other jurisdictions in compliance with laws and regulations. This material has not been reviewed by the Securities and Futures Commission of Hong Kong or any other regulator. https://support.hashkey.com/hc/en-gb/articles/34286118049945-HashKey-Exchange-News-Release-Standard-Terms-and-Disclaimers
台北2024年11月25日 /美通社/ -- 由昕力資*（7781）100%台灣研發的企業級API管理軟體- digiRunner，榮獲英國知名媒體所主辦的《全球銀行及金融獎》(Global Banking & Finance Awards®) 評選為2024年南亞洲最佳開放銀行APIs「Best Open Banking APIs Southern Asia 2024」，說明昕力有媲美國際大廠的軟體研發實力，並提供符合國內外中、大型企業IT治理需求的企業應用軟體。全球銀行與金融獎（Global Banking & Finance Awards®）由英國「GlobalBanking & Finance Review」雜誌於2011 年設立，獎項每年頒發一次，得獎者涵蓋全球銀行、保險、投資等領域的佼佼者，今年台灣共八家企業獲得殊榮，昕力是唯一獲獎的軟體科技公司，其它獲獎者均來自金融領域，包括：兆豐銀、新光金、元大銀...等優秀企業。 昕力此次獲獎，主要憑藉在台灣金融產業深耕多年的實力和經驗，根據各國不同的國情服務東南亞市場客戶，並取得初步成績，昕力在越南協助國泰世華銀行建立全數位消金系統，實現30分鐘完成借貸流程，讓越南民眾體驗數位金融的便捷；更協助越南國泰產險以AWS雲端技術架構建置對客戶端與業務員端兩大平台；同時，也協助世越銀行建置 API 管理中台，打造現代化 IT 的運營架構；昕力在柬埔寨，基於柬國央行欲推動全國的數位支付法規要求，協助國泰世華銀行開發合規的數位行動銀行。 昕力資訊董事長姚勝冨表示：「昕力資訊之企業級API管理軟體-digiRunner再度榮獲國際獎項，除公司軟體研發實力再度受到國際肯定外，今年度digiRunner業已完成AWS（Amazon）及GCP（Google）之認證及上架，均獲國際級大廠之技術認證及肯定，顯示公司國際級軟體水準及實力。近年越南政府編列及投入大量預算，協助越南企業進行數位轉型，昕力則複製臺灣金融業導入數位金融之成功經驗，布局越南當地保險市場，同時拓展ESG相關業務，樂觀看待南向佈局成績預計逐漸展現。」 國泰金控資深副總經理姚旭杰表示：「昕力資訊具備深厚的軟體研發實力，且多年來積極協同國泰金控多家子公司於東南亞發展布局，導入數位轉型與數位金融開發應用，是我們長期重要的合作夥伴。隨著越南成為國泰金拓展東南亞營運版圖的重點市場，我們不僅認同昕力資訊專注軟體、致力國際化發展的願景，也對其布局越南、協助企業發展深具信心。」 關於昕力資訊 昕力資訊為台灣第一國際級數位轉型軟體公司，憑藉軟體研發實力、模組化設計與 AI 核心科技，自主研發 DigiFusion 數位服務中台、SysTalk.ai 交談 AI 產品、ESGswift 永續及 GadoSecurity 企業安全防護等創新軟體產品，銷售通路遍及海內外。擁有跨國大型專案建置服務經驗，靈活因應各產業、市場的快速變化，以實現數位轉型提升企業競爭力。 訂閱昕力電子報 | 昕力官網 | 昕力Facebook | 昕力LinkedIn
CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host of new innovations coming to Vault CRM next year. With these new capabilities, companies can deploy AI that will have immediate value by boosting field productivity. CRM Bot embeds the large language model (LLM) of your choice into Vault CRM to enable a wide range of context-driven tasks including pre-call planning, suggested actions, recommended content, and context-specific learning. Planned for availability in late 2025, CRM Bot is included in Vault CRM for no additional charge and requires the Vault Direct Data API. AI-powered Voice Control brings the human voice as a user interface into Vault CRM by leveraging Apple Intelligence for hands-free operation of CRM via spoken commands. Planned for availability in late 2025, Voice Control is included in Vault CRM for no additional charge and requires Apple Intelligence and compatible devices. Delivering AI within its products – like CRM Bot and Voice Control – is part of Veeva's overall strategy to help enable AI for the life sciences industry. Veeva also provides the Vault Direct Data API for high-speed access to data needed for AI and the Veeva AI Partner Program that enables customers and partners to more easily build AI applications that integrate seamlessly with Vault applications. "Vault CRM Bot and Vault CRM Voice Control bring the latest advances in generative AI into Vault CRM for more effective, productive reps," said Arno Sosna, general manager of CRM products at Veeva. "Our product focus is to leverage AI for clear use cases with high impact and ensure smoother more effective deployments of advanced technologies." Veeva customers and life sciences industry professionals can learn about these innovations and more in the Vault CRM Product Roadmap session replay in Veeva Connect starting November 25. About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com. Veeva Forward-looking StatementsThis release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at sec.gov.
新加坡2024年11月23日 /美通社/ -- Nucleus Software 在新加坡舉行的 Synapse 2024 慶祝 30 年的轉型創新，印度與新加坡在銀行與科技領域蓬勃發展的夥伴關係達到新的里程碑。此活動突顯出公司在重新定義東南亞 (SEA) 和全球金融服務方面所扮演的角色，將金融和技術領域的領導者聚集在一起，探討銀行業未來的共同願景。 Mr. Vishnu R. Dusad, Co-Founder & Managing Director at Nucleus Software with other key dignitaries at Synapse2024. Synapse 2024 慶祝 Nucleus Software 在推動新加坡和東南亞金融生態系統的轉型變革方面，保持領導地位 30 週年。此活動也聚焦於 Global Finance & Technology Network (GFTN)，這是由新加坡金融管理局 (MAS) 支持的項目，旨在提倡以負責任的態度運用科技。此活動彰顯出印度和新加坡在共同致力於創新、跨界合作和金融包容性的推動下，不斷深化的協同效應。隨著人工智能、區塊鏈和數碼銀行領域的進步，金融服務業界正在迅速發展，這些合作關係正為建立更連結、更具彈性、更包容的全球生態系統奠定基礎。 Nucleus Software 共同創辦人兼執行董事 Vishnu R. Dusad 對這里程碑有所反思：「30 多年來，我們很榮幸能與新加坡晉升為全球金融強國的腳步同步。早在 1994 年，當我們選擇向東而不是向西發展時，這決定大膽而感性，因為我們相信新加坡是創新與合作的樞紐。我們當時所看到的，到今天依然真實：新加坡是全球金融環境的核心，是新思想紮根之地，也是夥伴關係蓬勃發展之地。」 這次活動匯聚了眾多傑出的參與者，突顯印度與新加坡合作的轉型潛力。星展集團 (DBS) 行政總裁兼主禮嘉賓 Piyush Gupta 先生在開場致詞中為活動定下基調，強調在數碼時代中，大科技在可擴充、以客戶為中心的金融服務時所扮演的轉型角色。 在他的演講之後，主要發言人以其見解豐富了討論內容。MAS 首席金融科技總監兼 GFTN 集團指定行政總裁 Sopnendu Mohanty 先生強調，推動採用負責任技術和建立包容性金融生態系統的重要性。Vinod Rai 先生是備受世界尊崇的公共政策專家、新加坡國立大學傑出客席研究員、前印度審計總長分享了他對金融體系治理和政策框架的看法。Nucleus Software 公司董事長、印度前國防部長 S.M. Acharya 先生，就如何運用科技使銀行架構現代化及安全化，提出前瞻性的展望。 最後，全球金融科技先驅和深度科技創新者 GFTN（日本）共同創辦人兼董事 Pieter Franken 先生，討論了去中心化金融的未來及其對金融部門的影響。 此活動展示了科技在全球金融系統中的變革性角色，強調為可擴展性和包容性設定基準的創新。嘉賓討論了本地化解決方案的重要性、跨境整合的挑戰，以及運用雙重商業模式以優化資本並促進公眾參與。對話強調了需要共同標準、API 等統一框架以及加速財務包容，並在數碼時代推動全球聯繫的合作努力。 30 年來，Nucleus Software 一直推出先進的貸款和銀行解決方案，以支持金融機構在新加坡和東南亞不斷變化的需求。Nucleus Software 在驗收測試驅動開發 (ATDD) 和持續集成/持續交付 (CICD) 等精益開發方法的驅動下，繼續在高效、靈活和安全的金融科技領域推陳出新。
CHENGDU, China, Nov. 22, 2024 /PRNewswire/ -- On November 19, Qilianshan Pharmaceutical Co., Ltd. (Qilian Pharma), a subsidiary of BGM Group Ltd, welcomed a team of experts from Guilin Pharmaceutical Co., Ltd. (Guilin Pharma), including Quality Assurance Engineer Ms. Shen and Technical Manager Ms. An. The purpose of their visit was to conduct an on-site audit to pave the way for future cooperation between the two companies. Guilin Pharma, a member company of Fosun Pharma, is a comprehensive pharmaceutical enterprise specializing in the research, development, production, and sales of chemical drugs. With a product portfolio that includes tablets, capsules, injections, and active pharmaceutical ingredients across four major categories and over 200 varieties, Guilin Pharma stands as the leading pharmaceutical exporter in Guangxi Province, China. Throughout the visit, Mr. Lu, the Executive Deputy General Manager of Qilian Pharma, along with other management personnel, accompanied the audit team. They provided a comprehensive overview of the company's innovative production processes, product features, quality, and market competitive advantages. The audit team conducted an in-depth review of key areas, including the production workshop, raw material warehouse, and quality testing center. They commended Qilian Pharma for the rigor of its production processes, the advancement of its equipment and facilities, their maintenance status, and the cleanliness and efficient management of the production environment. Both parties collaboratively identified and optimized potential improvement points in the production process, setting clear direction and goals for further enhancing product quality and customer service levels. This effort aims to increase customer satisfaction and loyalty. BGM Group is committed to producing safe, effective, and affordable pharmaceutical ingredients to elevate global healthcare standards. We will continue to provide our customers with high-quality products and services. About BGM Group Ltd BGM Group Ltd, headquartered in Chengdu, China, is an innovative company dedicated to the fields of biopharmaceuticals, bio-extraction, and medical health. Our current product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. The oxytetracycline API not only provides raw materials for pharmaceutical companies to produce human antibiotics but also supports the global breeding and livestock industries to ensure the safety of poultry and seafood. The crude heparin sodium, after processing by downstream companies, is transformed into refined heparin sodium and heparin sodium injection solutions, which are major anticoagulants. Licorice preparations, such as compound licorice lozenges, are used as cough suppressants and supplied to retail pharmacies. For more information, visit the Company's website at: https://www.bgmgroupltd.com/ Safe Harbor Statement This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook" and similar statements. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law. For investor and media inquiries, please contact:info@qiliancorp.com
A12 藝術空間
#API
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
